Research
Hormonal
Treatment proposals for obesity must be individualized according to phenotyping.
Tailoring obesity treatment plans to individual profiles can enhance effectiveness.
StrongSupportsmedium confidence
Treatment proposals must be individualized according to phenotyping.
Why this rating
The claim is supported by a systematic approach to treatment based on phenotyping.
Source
Obesity and its treatment: Toward new approaches
Bérénice Segrestin et al. · Annales d Endocrinologie · 2025
DOI 10.1016/j.ando.2025.101712
reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →